Repatha and Prolia position

Good choice to move over to Gen Med….Enbrel is a sinking ship! especially in Derm

 

The money isn't even good anymore. If you're good, keep looking.

 

I see Prolia growing nicely - is this really a Gen Med product. Heard buy and bill is a real problem. Hate to come into a down hill ride.

 

"Primary Care" reps were hired on as specialty reps and that is why the base is high. At launch, we called on all the specialties. Buy and bill is also not a primary care role.

 

Don't do it. This place is a shit hole.

 

and gen med has more Repatha insurance verifications than the CV and cardiologists. definitely a bu that consistently over delivers. No one thought Primary Care would take off this fast.

 

80% of the Prolia business is from General medicine. Specialty is slowing down and less referrals happening. Amgen was the first to launch biologics to gen med and the physicians now refer less due to the help from Amgen figuring out the access. It is a pretty cool new medical area, and growing! Unfortunately specialty is shrinking overall and even residencies for specialty docs are decreasing as with new regulation don't see the payout in becoming a specialist like they used to. You can see it happening with Repatha too, Gen Med using this as much (even more in some areas) and early as Cardios - LDL is not something most Gen Med refer for.

 

Gen Med definitely the place to go with Prolia and Repatha. HQ Gen Med is surprising everyone with this launch too with way more patients than HQ excepted, more than CV which is crazy because they built that whole sales force. CV is really hurting in some places because they don't have the access they should. I heard that there are whole territories with just CV 1-3 patients even in the system - after 6 weeks. That is unbelievable for a product like this! The problem is that CV didn't always hire reps with relationships and it is killing them. CV will be RIF soon. They needed to be faster out at launch to establish the CV market and they are way slower than expected. Big disappointment.

 

All cultures are really bad except for Gen Med that has all growth

 

because the majority of the Prolia business comes from Gen Med and very little specialty. Also primary care office need tons of help with access so depend on rep so much that the job is now identified as needing higher level reps . Walking through an office that has never did buy and bill before vs. an established DDD account takes a certain type of rep. That is why they are getting paid way more. I am jumping over as soon as I can. Also they are kicking butt with Repatha, way more than cardiologists. no one refers for LDL anymore. Also Prolia paved the way for these offices to use a biologic and spec pharm. Great set up.